BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Koskensalo V, Tenca A, Udd M, Lindström O, Rainio M, Jokelainen K, Kylänpää L, Färkkilä M. Diclofenac does not reduce the risk of acute pancreatitis in patients with primary sclerosing cholangitis after endoscopic retrograde cholangiography. United European Gastroenterol J 2020;8:462-71. [PMID: 32213036 DOI: 10.1177/2050640620912608] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Waldthaler A, Schramm C, Bergquist A. Present and future role of endoscopic retrograde cholangiography in primary sclerosing cholangitis. Eur J Med Genet 2021;64:104231. [PMID: 33905896 DOI: 10.1016/j.ejmg.2021.104231] [Reference Citation Analysis]
2 Koskensalo V, Aronen P, Färkkilä M, Kylänpää L, Lindström O, Rainio M, Udd M, Jokelainen K, Tenca A. Use of thiopurines is not a risk factor for post-ERC pancreatitis in patients with primary sclerosing cholangitis. Dig Liver Dis 2021;53:1020-7. [PMID: 34116970 DOI: 10.1016/j.dld.2021.05.009] [Reference Citation Analysis]
3 Keihanian T, Barakat MT, Tejaswi S, Mishra R, Carlson CJ, Brandabur JJ, Girotra M. Role of Endoscopic Retrograde Cholangiopancreatography in the Diagnosis and Management of Cholestatic Liver Diseases. Clin Liver Dis 2022;26:51-67. [PMID: 34802663 DOI: 10.1016/j.cld.2021.08.006] [Reference Citation Analysis]